| 1. |
Wei Y, Bai L. Recent advances in the understanding of molecular mechanisms of cartilage degeneration, synovitis and subchondral bone changes in osteoarthritis[J]. Connect Tissue Res, 2016, 57(4):245-261.
|
| 2. |
Dalirfardouei R, Karimi G, Jamialahmadi K. Molecular mechanisms and biomedical applications of glucosamine as a potential multifunctional therapeutic agent[J]. Life Sci, 2016, 152:21-29.
|
| 3. |
Barthe L, Woodley J, Lavit M, et al. In vitro intestinal degradation and absorption of chondroitin sulfate, a glycosaminoglycan drug[J]. Arzneimittelforschung, 2004, 54(5):286-292.
|
| 4. |
Bruyere O, Cooper C, Pelletier JP, et al. A consensus statement on the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO) algorithm for the management of knee osteoarthritis-from evidence-based medicine to the real-life setting[J]. Semin Arthritis Rheum, 2016, 45 (Suppl 4):S3-S11.
|
| 5. |
Bruyere O, Altman RD, Reginster JY. Efficacy and safety of glucosamine sulfate in the management of osteoarthritis:evidence from real-life setting trials and surveys[J]. Semin Arthritis Rheum, 2016, 45 (Suppl 4):S12-S17.
|
| 6. |
Mantovani V, Maccari F, Volpi N. Chondroitin sulfate and glucosamine as disease modifying anti-osteoarthritis drugs (DMOADs)[J]. Curr Med Chem, 2016, 23(11):1139-1151.
|
| 7. |
Bascoul-Colombo C, Garaiova I, Plummer SF, et al. Glucosamine hydrochloride but not chondroitin sulfate prevents cartilage degradation and inflammation induced by interleukin-1α in bovine cartilage explants[J]. Cartilage, 2016, 7(1):70-81.
|
| 8. |
Osório J. Osteoarthritis:glucosamine plus chondroitin sulfate:long-term therapy could retard progression of knee OA[J]. Nat Rev Rheumatol, 2016, 12(4):192.
|
| 9. |
Kang YH, Park S, Ahn C, et al. Beneficial reward-to-risk action of glucosamine during pathogenesis of osteoarthritis[J]. Eur J Med Res, 2015, 20(20):89.
|
| 10. |
Hussain SM, Neilly DW, Baliga S, et al. Knee osteoarthritis:a review of management options[J]. Scott Med J, 2016, pii:0036933015619588.
|
| 11. |
Bishnoi M, Jain A, Hurkat P, et al. Chondroitin sulphate:a focus on osteoarthritis[J]. Glycoconj J, 2016,[Epub ahead of print].
|
| 12. |
Chen B, Zhan H, Marszalek J, et al. Traditional Chinese medications for knee osteoarthritis pain:a Meta-Analysis of randomized controlled trials[J]. Am J Chin Med, 2016, 44(4):677-703.
|
| 13. |
Carbone A, Rodeo S. A review of current understanding of post-traumatic osteoarthritis resulting from sports injuries[J]. J Orthop Res, 2016.
|
| 14. |
Ontario HQ. Arthroscopic lavage and debridement for osteoarthritis of the knee:an evidence-based analysis[J]. Ont Health Technol Assess Ser, 2005, 5(12):1-37.
|
| 15. |
Jones BQ, Covey CJ, Sineath J. Nonsurgical management of knee pain in adults[J]. Am Fam Physician, 2015, 92(10):875-883.
|
| 16. |
Yu SP, Hunter DJ. Managing osteoarthritis[J]. Australian Prescriber, 2015, 38(4):115-119.
|
| 17. |
Tsuji T, Yoon J, Kitano N, et al. Effects of N-acetyl glucosamine and chondroitin sulfate supplementation on knee pain and self-reported knee function in middle-aged and older Japanese adults:a randomized, double-blind, placebo-controlled trial[J]. Aging Clin Exp Res, 2016, 28(2):197-205.
|
| 18. |
Kongtharvonskul J, Anothaisintawee T, McEvoy M, et al. Efficacy and safety of glucosamine, diacerein, and NSAIDs in osteoarthritis knee:a systematic review and network meta-analysis[J]. Eur J Med Res, 2015, 20:24.
|
| 19. |
Gelber AC. Conventional medical therapy for osteoarthritis:current state of the evidence[J]. Curr Opin Rheumatol, 2015, 27(3):312-317.
|
